Improved characterization of cancer identified on mpMRI may be achieved with the incorporation of prostate-specific antigen density (PSAD) and apparent diffusion coefficient (ADC) values to the PI-RADS v2 guidelines (2, 3). This evidence concerns the gene KLK3 and cancer.